Study evaluates citalopram for Alzheimer's-related agitation

02/19/2014 | HealthDay News

Alzheimer's disease patients suffering from agitation who received the antidepressant citalopram for nine weeks showed significant reductions in agitation symptoms compared with those who took a placebo, according to a study in the Journal of the American Medical Association. Citalopram users, however, had a greater risk of slightly decreased mental function and abnormal heart function. Citalopram at lower doses may be an alternative to antipyschotic drugs, the standard treatment for Alzheimer's-linked agitation, the study's lead author said.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC